Gubra A/S (CPH:GUBRA)

Denmark flag Denmark · Delayed Price · Currency is DKK
330.60
+7.20 (2.23%)
Apr 28, 2026, 4:59 PM CET
-6.61%
Market Cap 5.28B
Revenue (ttm) 2.64B
Net Income (ttm) 1.69B
Shares Out 16.33M
EPS (ttm) 102.70
PE Ratio 3.15
Forward PE 38.05
Dividend n/a
Ex-Dividend Date n/a
Volume 60,570
Average Volume 31,569
Open 322.00
Previous Close 323.40
Day's Range 316.00 - 352.00
52-Week Range 293.00 - 571.00
Beta 0.45
RSI 41.75
Earnings Date Aug 20, 2026

About Gubra

Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry; and various services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, bioinfor... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 300
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol GUBRA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.